Citation
(2004), "BIOSIS pursues final negotiations with bidder", The Electronic Library, Vol. 22 No. 1. https://doi.org/10.1108/el.2004.26322aab.011
Publisher
:Emerald Group Publishing Limited
Copyright © 2004, Emerald Group Publishing Limited
BIOSIS pursues final negotiations with bidder
BIOSIS pursues final negotiations with bidder
The Board of Trustees of Biological Abstracts has announced that it has voted to pursue final negotiations with The Thomson Corporation leading to a potential sale of the publishing assets of Biological Abstracts, Inc and BIOSIS, UK.
Founded in 1926, BIOSIS produces vital databases and services for life sciences research, including Biological Abstracts, BIOSIS Previews and Zoological Record. These databases are made available globally on a wide variety of platforms, including the Thomson ISI Web of Knowledge.
Thomson/ISI was selected from a number of potential strategic partners following a detailed review process by the BIOSIS Board. After considering both not-for-profit and for-profit organizations, the Board believes that Thomson/ISI is in a unique position to best fulfil the BIOSIS mission "to facilitate the understanding of the living world by helping researchers, educators, students and others access information relevant to the life sciences".
Chairman of the Board, Dr James H Beach explained the Board's choice to finalize negotiations with Thomson/ISI: "Thomson/ISI has a history of providing quality services to the global community of life science researchers in both academic and corporate markets. Of the many potential bidders we considered, Thomson/ISI seems best prepared to successfully manage and enhance BIOSIS publishing services, while increasing the products' dissemination in the life science research community".
As part of the bidding process Thomson has partnered with CAB International, one of the leading not-for-profit publishers in the applied life sciences.
"BIOSIS databases are preeminent sources for the biological research community and we are excited about the prospect of pairing this content with highly-regarded Thomson databases to offer high quality information resources to researchers", said Mike Tansey, president and CEO of Thomson Scientific. "We look forward to working with the BIOSIS Board of Directors over the coming weeks to make this opportunity a reality".